A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on “Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody”

Saved in:
Bibliographic Details
Published in:Journal of dermatology 2023-01, Vol.50 (1), p.e39-e40
Main Authors: Koizumi, Haruka, Muro, Yoshinao, Imai, Satoko, Yamashita, Yuta, Ogawa‐Momohara, Mariko, Takeichi, Takuya, Murakami, Megumi, Mitsuma, Teruyuki, Akiyama, Masashi
Format: Article
Language:English
Subjects:
Autoantibodies
Case reports
Dermatomyositis
Dermatomyositis - chemically induced
Dermatomyositis - diagnosis
Dermatomyositis - drug therapy
Enzyme-Linked Immunosorbent Assay
Humans
Immunotherapy
Mediation Analysis
Monoclonal antibodies
Pembrolizumab
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0385-2407
1346-8138
DOI:10.1111/1346-8138.16587